How effective is Nitrofurantoin for Recurrent Cystitis? (a real world drug study)

Summary:

Overall ratings: 3.3/5
Long term ratings: 4.5/5

This is a phase IV clinical study of how effective Nitrofurantoin (nitrofurantoin, macrocrystalline) is for Recurrent cystitis and for what kind of people. The study is created by eHealthMe from 9 Nitrofurantoin users and is updated continuously.

What is Nitrofurantoin?

Nitrofurantoin has active ingredients of nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 4,838 Nitrofurantoin users. Check the latest studies of Nitrofurantoin.

What is Recurrent cystitis?

Recurrent cystitis (repeated inflammation of the bladder) is found to be associated with 8 conditions by eHealthMe. Check the latest studies of Recurrent cystitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.


On Aug, 22, 2026

9 people are studied for taking Nitrofurantoin in Recurrent cystitis

Overall effectiveness (number of people):

Does Nitrofurantoin work for your Recurrent cystitis (overall)?

Long term (1+ years) effectiveness (number of people):

Does Nitrofurantoin work for your Recurrent cystitis (long term)?

Nitrofurantoin effectiveness for Recurrent cystitis (number of people):

Overall:
  • not at all: 0
  • somewhat: 3
  • moderate: 2
  • high: 2
  • very high: 2
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 0
  • high: 1
  • very high: 1

Gender of people who take Nitrofurantoin for Recurrent cystitis *:

  • female: 88.89 %
  • male: 11.11 %

Age of people who take Nitrofurantoin for Recurrent cystitis *:

  • 0-1: 0.0 %
  • 2-9: 11.11 %
  • 10-19: 0.0 %
  • 20-29: 33.33 %
  • 30-39: 0.0 %
  • 40-49: 11.11 %
  • 50-59: 11.11 %
  • 60+: 33.33 %

Who find Nitrofurantoin more effective for Recurrent Cystitis?

Gender of people who take Nitrofurantoin for Recurrent cystitis *:

  • female: 100 %
  • male: 0.0 %

Age of people who take Nitrofurantoin for Recurrent cystitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 50 %
  • 30-39: 0.0 %
  • 40-49: 25 %
  • 50-59: 25 %
  • 60+: 0.0 %

* Approximation only. Some reports may have incomplete information.

Do you take Nitrofurantoin?

- You can start a phase IV clinical trial to monitor Nitrofurantoin safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on nitrofurantoin, macrocrystalline (the active ingredients of Nitrofurantoin) and Nitrofurantoin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: